NSAID hypersensitivity reaction
Drug reaction · Allergy / Immunology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Reactions to NSAIDs ranging from NSAID-exacerbated respiratory disease (rhinosinusitis/asthma) to urticaria/angioedema and, less commonly, anaphylaxis; many are pharmacological (COX-1 mediated) rather than IgE-mediated and cross-react across NSAIDs.
Red flags
- Laryngeal oedema / airway compromise
- Severe bronchospasm
- Hypotension (anaphylaxis)
- Reaction to multiple chemically unrelated NSAIDs (cross-reactive phenotype)
Assessment
Differential diagnosis
- IgE-mediated single-NSAID anaphylaxis
- Chronic spontaneous urticaria flare
- ACE-inhibitor angioedema
- Asthma exacerbation from other trigger
Investigations
- Detailed drug and reaction history (single agent vs cross-reactive pattern)
- Assess airway, breathing and circulation acutely
- Serial tryptase if anaphylaxis suspected
- Later specialist assessment / supervised drug provocation
Management
- Stop the NSAID and remove exposure
- Treat the manifestation: bronchodilators/oxygen for respiratory disease, antihistamines for urticaria/angioedema
- Treat true anaphylaxis with IM adrenaline
- Give corticosteroids for significant respiratory or cutaneous involvement
- Advise avoidance of all COX-1 inhibitors in cross-reactive patients (a selective COX-2 inhibitor may be tolerated under specialist guidance)
- Refer to allergy/immunology for characterisation
Drugs & doses
Stop the NSAID
Antihistamine for urticaria/angioedema
Bronchodilators and oxygen for respiratory symptoms
IM adrenaline if anaphylaxis
Corticosteroids for significant reactions
Disposition
Discharge after treatment with avoidance advice; allergy referral to characterise and identify safe alternatives.
Complications & pitfalls
- Anaphylaxis
- Severe bronchospasm
- Recurrent reactions with re-exposure
Exam pearls
- Cross-reactivity across chemically unrelated NSAIDs points to a COX-1 (pharmacological) mechanism rather than true allergy
- Patients with cross-reactive disease may tolerate a selective COX-2 inhibitor under specialist guidance
- Aspirin-exacerbated respiratory disease is the classic triad of asthma, nasal polyps and NSAID sensitivity
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.